ENDRA Life Sciences Inc. (NDRA)

Market Cap	6.27M
Revenue (ttm)	n/a
Net Income (ttm)	-9.89M
Shares Out	70.27M
EPS (ttm)	-1.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,605,154
Open	0.0927
Previous Close	0.0928
Day's Range	0.0862 - 0.0927
52-Week Range	0.0690 - 2.7900
Beta	1.06
Analysts	Strong Buy
Price Target	8.00 (+8,868.61%)
Earnings Date	Aug 12, 2024

About NDRA

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was in...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 9, 2017
• Employees: 21
• Stock Exchange: NASDAQ
• Ticker Symbol: NDRA

Analyst Forecast

According to one analyst, the rating for NDRA stock is "Strong Buy" and the 12-month stock price forecast is $8.0.

Price Target

$8.0

(8,868.61% upside)

Analyst Consensus: Strong Buy